Incyte INCY
NASDAQ INCY
$126.75 -1.25 (-0.98%)
As of: Sep 4, 2026 · 3:59 PM EDT

Incyte (INCY) Change in Account Payables (2010 - 2026)

Incyte's (INCY) quarterly Change in Account Payables came in at $22.4 million in Q2 2026, up 12.66% YoY from $19.9 million in Q2 2025, and down 4.34% on a QoQ basis from $23.4 million in Q1 2026.

Analysis

Incyte (INCY) Change in Account Payables (2010 - 2026) Analysis & Trends

Incyte (INCY) has 17 years of Change in Account Payables data on file, last reported at $22.4 million in Q2 2026.

  • Quarterly Change in Account Payables rose 12.66% year-over-year to $22.4 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $34.7 million (down 48.48% YoY) and the FY2025 annual result came in at $6.6 million, down 92.56% from the prior year.
  • Change in Account Payables declined to $22.4 million in Q2 2026, from $23.4 million in the prior quarter.
  • In the past five years, Change in Account Payables ranged from a high of $114.4 million in Q4 2022 to a low of -$221.9 million in Q1 2023.
  • A 5-year average of $4.3 million and a median of $19.5 million in 2024 frame the typical range for Change in Account Payables.
  • Annual changes were most pronounced in 2023 — Change in Account Payables sank 1034.35% — and 2026, when it soared 1186.1%.
  • Tracing INCY's Change in Account Payables over 5 years: stood at $114.4 million in 2022, then plunged by 126.06% to -$29.8 million in 2023, then soared by 163.9% to $19.0 million in 2024, then soared by 73.1% to $33.0 million in 2025, then tumbled by 31.98% to $22.4 million in 2026.
  • The last three Change in Account Payables figures came in at $22.4 million (Q2 2026), $23.4 million (Q1 2026), and $33.0 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Account Payables (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn -66.70 Mn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn -
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -8.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - 5.03 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 37.53 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn -
8 Royalty Pharma 28.45 Bn 27.61 Bn - -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn -
10 Incyte 25.44 Bn 20.91 Bn 1.57 Bn 22.43 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 22.43 Mn
Mar 31, 2026 23.45 Mn
Dec 31, 2025 32.98 Mn
Sep 30, 2025 -44.17 Mn
Jun 30, 2025 19.91 Mn
Mar 31, 2025 -2.16 Mn
Dec 31, 2024 19.05 Mn
Sep 30, 2024 30.54 Mn
Jun 30, 2024 -16.06 Mn
Mar 31, 2024 54.64 Mn
Dec 31, 2023 -29.81 Mn
Sep 30, 2023 -16.13 Mn
Jun 30, 2023 99.91 Mn
Mar 31, 2023 -221.91 Mn
Dec 31, 2022 114.37 Mn
Sep 30, 2022 -31.60 Mn
Jun 30, 2022 42.22 Mn
Mar 31, 2022 -19.56 Mn
Dec 31, 2021 57.60 Mn
Sep 30, 2021 -7.59 Mn